Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation routing

Prioritisation routing

Decision

Decision

Showing 76 to 100 of 373

TitlePrioritisation routingDecisionDecision date
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]None selectedNot selected
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]None selectedNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]None selectedNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]None selectedAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]None selectedAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]None selectedNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]None selectedNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353None selectedNot selected
Transbronchial lung cryobiopsyNone selectedAwaiting decision
Noninvasive Vagus Nerve Stimulation For reactive airway diseaseNone selectedFurther information required
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]None selectedNot selected
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]None selectedNot selected
Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]None selectedAwaiting decision
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]None selectedNot selected
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]None selectedNot selected
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]None selectedn/a
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]None selectedNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]None selectedNot selected
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]None selectedNot selected
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic herniaNone selectedFurther information required
Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All